Hepatitis viruses take advantage of traditional practices to increase the burden of hepatocellular carcinoma in Tunisia.


Journal

Archives of virology
ISSN: 1432-8798
Titre abrégé: Arch Virol
Pays: Austria
ID NLM: 7506870

Informations de publication

Date de publication:
Jan 2020
Historique:
received: 19 05 2019
accepted: 26 08 2019
pubmed: 21 10 2019
medline: 18 1 2020
entrez: 21 10 2019
Statut: ppublish

Résumé

Hepatocellular carcinoma (HCC) is a major public health issue in Africa. In Tunisia, hepatitis B virus (HBV) is known to be an important risk factor for HCC in the south of the country, but the role played by hepatitis C virus (HCV) still remains unclear. The aim of the current case-control study was to identify risk factors for HCC development in the northern part of the country. Clinical and biological data including viral hepatitis status (serological and molecular) and non-infectious risk factors from 73 patients with HCC and 70 control subjects without hepatic diseases were collected. The mean age of the patients was 63 ± 10 years, and the ratio of males to females was 1.1. HCC occurred in cirrhotic liver in 72.0% of the cases. HCV infection was the dominant risk factor (64.3% of cases); the presence of HBV was observed in 53.4% of the cases. Occult hepatitis B and C were implicated, respectively, in 30.1% and 9.6% of the cases. HCV genotype 1b was predominant. Patients originating from western Tunisia formed a homogeneous group, characterized by significantly higher rates of tattoos or scarifications (83%) and HCV infection (80%) than those from other parts of the country. Chronic HCV infection is currently the primary risk factor for HCC in Tunisia; HBV infection remains frequent in its overt or occult infection forms. Traditional esthetic practices apparently contribute to increasing the burden of terminal liver diseases in western Tunisia.

Identifiants

pubmed: 31630275
doi: 10.1007/s00705-019-04440-5
pii: 10.1007/s00705-019-04440-5
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

33-42

Auteurs

Ines Dhifallah (I)

Laboratory of Clinical Virology, Pasteur Institute of Tunis 13, Place Pasteur, Le Belvedere PB 74, 1002, Tunis, Tunisia. dhifallah.ines@yahoo.fr.
Faculty of Sciences of Bizerte, University of Carthage, Tunis, Tunisia. dhifallah.ines@yahoo.fr.

Marwa Khedhiri (M)

Laboratory of Clinical Virology, Pasteur Institute of Tunis 13, Place Pasteur, Le Belvedere PB 74, 1002, Tunis, Tunisia.
Faculty of Sciences of Tunis, University of Manar, Tunis, Tunisia.

Anissa Chouikha (A)

Laboratory of Clinical Virology, Pasteur Institute of Tunis 13, Place Pasteur, Le Belvedere PB 74, 1002, Tunis, Tunisia.

Ghassen Kharroubi (G)

Laboratory of Medical Epidemiology, Pasteur Institute of Tunis, Tunis, Tunisia.

Walid Hammami (W)

Laboratory of Clinical Virology, Pasteur Institute of Tunis 13, Place Pasteur, Le Belvedere PB 74, 1002, Tunis, Tunisia.

Amel Sadraoui (A)

Laboratory of Clinical Virology, Pasteur Institute of Tunis 13, Place Pasteur, Le Belvedere PB 74, 1002, Tunis, Tunisia.

Mohamed Msaddek Azzouz (MM)

Department of Gastroenterology, Hospital of Tahar Maamouri, Faculty of Medicine, University of Manar, Tunis, Tunisia.

Nadia Maamouri (N)

Department of Gastroenterology B, La Rabta Hospital, Faculty of Medicine, University of Manar, Tunis, Tunisia.

Tahar Khalfallah (T)

Department of General Surgery, Hospital of Mongi Slim, La Marsa, Faculty of Medicine, University of Manar, Tunis, Tunisia.

Henda Triki (H)

Laboratory of Clinical Virology, Pasteur Institute of Tunis 13, Place Pasteur, Le Belvedere PB 74, 1002, Tunis, Tunisia.

Pascal Pineau (P)

Nuclear Organization and Oncogene Unit, INSERM U993, Pasteur Institue, Paris, France.

Olfa Bahri (O)

Laboratory of Clinical Virology, Pasteur Institute of Tunis 13, Place Pasteur, Le Belvedere PB 74, 1002, Tunis, Tunisia. bahri.olfa@planet.tn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH